Actively Recruiting
Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention
Led by Beijing Anzhen Hospital · Updated on 2026-05-13
176
Participants Needed
1
Research Sites
88 weeks
Total Duration
On this page
Sponsors
B
Beijing Anzhen Hospital
Lead Sponsor
W
Wuhan Asia Heart Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this multicenter, randomized trial is to compare standby cannulated ECMO versus prophylactic ECMO in patients undergoing high-risk percutaneous coronary intervention (PCI). The main question it aims to answer is : • If standby cannulated ECMO as compared with prophylactic ECMO will improve the outcomes in patients undergoing high-risk PCI
CONDITIONS
Official Title
Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinician decision to perform PCI with ECMO support
- Age 18 years or older
- Compromised heart function with ejection fraction less than 35%, or at risk of hemodynamic deterioration, or intervention on last patent coronary conduit or unprotected left main artery, or complex 3-vessel disease with SYNTAX score of 33 or higher
- Informed consent provided
You will not qualify if you...
- Cardiogenic shock requiring inotropes, pressors, or mechanical support to maintain systolic blood pressure above 90 mmHg
- Moderate to severe aortic insufficiency
- Severe peripheral vascular disease
- Creatinine level 4 mg/dL or higher
- Liver dysfunction with liver enzymes and bilirubin levels elevated to 3 times the upper limit of normal or more
- History of stroke or transient ischemic attack within the past month
- Abnormal blood clotting defined as platelet count 50,000/mm3 or lower or fibrinogen 1.50 g/L or lower
- Allergy or intolerance to heparin, aspirin, ADP receptor inhibitors, or documented heparin-induced thrombocytopenia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China, 100029
Actively Recruiting
Research Team
X
Xiaotong Hou, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here